Gilead Sciences

GSK
Pharma

GSK allows generic versions of cabotegravir for HIV treatment

GSK has expanded its agreement with the Medicines Patent Pool, allowing generic production of cabotegravir as an HIV treatment in poorer nations.
Kevin Dunleavy Jul 15, 2025 2:16pm
Realistic white price tags collection Special offer or shopping discount label
Favicon Fierce Biotech

China biotechs ‘reshaping’ US biopharma: Jefferies report

Jul 14, 2025 2:30pm
Leo

Leo ponies up €90 million for Boehringer Ingelheim's Spevigo

Jul 14, 2025 8:25am
Gilead Sciences

Gilead enlists Global Fund in access campaign for new PrEP med

Jul 9, 2025 4:42pm
US Supreme Court

SCOTUS ruling enables smooth Yeztugo launch: analyst

Jul 1, 2025 9:24am
FDA Building

FDA removes barrier to CAR-Ts; move likely to boost uptake

Jun 27, 2025 11:14am